This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Jan. 24, 2013

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Do you have a company or organization that has initiated a highly innovative program focused on preventative measures and lifestyle changes? Nominate them for the NAMCP Prevention and Lifestyle Change Innovation Award. Please Click here to download the application for more information.

Please click here to view Eisai's 2012 Oncology Digest. The PDF contains two articles and the final oncology digest.

Please click here to view the webcast on Eisai's 2012 Oncology Digest from the Fall Managed Care Forum.

Register today
Spring Managed Care Forum
May 2-3, 2013
Gaylord Palms
Orlando, Fla.

The NAMCP Behavioral Health Institute (BHI) is pleased to recognize the WVP Health Authority as the 2012 Behavioral Health Innovation Award winner.

Click here for the press release!

Click Here to view the Journal of Managed Care Medicine

Click Here to view our Complimentary Online CME/CEU Webcasts

Announcing the NAMCP Medical Directors Breast Cancer Resource Center. Click here to visit the website.



Study finds how genes that cause illness work
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
It has been one of the toughest problems in genetics. How do investigators figure out not just what genes are involved in causing a disease, but what turns those genes on or off? What makes one person with the genes get the disease and another not? Now, in a pathbreaking paper, researchers at the Johns Hopkins University School of Medicine and the Karolinska Institute in Sweden report a way to evaluate one gene-regulation system: chemical tags that tell genes to be active or not. More

Blood test might spot high-risk breast cancer genes
HealthDay News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new blood-based genetic test may predict the presence of dangerous BRCA1 or BRCA2 gene mutations in women, a new study finds. These mutations significantly boost the risk for breast or ovarian cancer, which often develop at an early age in women with the mutations. More

It's legal for some insurers to discriminate based on genes
NPR    Share    Share on FacebookTwitterShare on LinkedinE-mail article
VideoBriefGetting the results of a genetic test can be a bit like opening Pandora's box. You might learn something useful or interesting, or you might learn that you're likely to develop an incurable disease later on in life. There's a federal law that's supposed to protect people from having their own genes used against them, the Genetic Information Nondiscrimination Act. The law has a loophole: It only applies to health insurance. It doesn't say anything about companies that sell life insurance, disability insurance or long-term-care insurance. More

 Biotech/Diagnostics/Personalized Medicine

May Clinic partners with firm to further personalized medicine
MedCity News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Mayo Clinic announced it is partnering with Silicon Valley Biosystems, a California diagnostics company, to provide better genomics diagnostics and interpretation. Under the agreement, SV Bio will provide its genome interpretation solution services and clinical decision support services to Mayo. Mayo will use that to provide better genomics interpretation to providers worldwide. More

Earn your MS in Nursing Online

Nursing@Georgetown is a Master’s in Nursing program delivered online by Georgetown University’s renowned School of Nursing & Health Studies. These programs are designed to help the next generation of nursing leaders achieve their career goals while improving the health and well-being of all people. MORE

Targeted enzyme replacement can treat X-linked myotubular myopathy
Medical College of Wisconsin via The Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A collaborative research team including a Medical College of Wisconsin pediatric neuropathologist successfully mitigated some of the effects of a muscular disease by using a new targeted enzyme replacement therapy strategy from 4s3 Bioscience. The findings are published in a recent edition of Human and Molecular Genetics. More

 Regenerative Medicine

Researchers grow kidney tissue from stem cells
Agence France-Presse via Google News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers in Japan say they have succeeded in growing human kidney tissue from stem cells for the first time in a potential breakthrough for millions with damaged organs who are dependent on dialysis. More

Stanford lab creates HIV-resistant cells
San Francisco Chronicle    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Stanford scientists have developed a technique to genetically engineer certain immune cells and make them resistant to HIV — a technique that, if proved successful in human subjects, could provide an alternative to the lifetime of medication that people with HIV infections now face. More

 Emerging Medical Technologies

FDA approves 1st skin patch to combat migraines
HealthDay News via U.S. News & World Report    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A skin patch for the treatment of migraines, and the intense waves of nausea that often accompany these debilitating headaches, has been approved by the U.S. Food and Drug Administration. Called Zecuity, the patch contains sumatriptan, one of the most widely prescribed medications for migraines. More

Discover the Concentra Difference.

Concentra offers medical practice expertise, operational and peer support, and long-term stability to enable your professional and financial success. Our providers work consistent schedules that encourage healthy work-life balance, and experience the satisfaction of working in an environment designed to reduce administrative burden while allowing more time for patient care.

Report: Medical devices neglected in EHR chase
InformationWeek    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Interoperability of health information has been heralded for decades as a way to make medicine more effective, efficient and safer. But the focus at the national policy level on electronic health records might be neglecting another important part of the equation, namely interoperability of vast amounts of data coming from increasingly smarter medical devices. More

 Managed Healthcare News

Kaiser study finds Medicaid coverage gaps in US states
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
U.S. adults who qualify for Medicaid often must have incomes well below the federal poverty line, while adults who have no dependent children are allowed to receive benefits in only nine of the 50 states, according to a new survey. More

HMO-like plans may be poised for comeback in online insurance markets
Kaiser Health News and USA Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
It's back to the future for insurers, which plan to sharply limit the choice of doctors and hospitals in some policies marketed to consumers under the health law, starting next fall. Limited network plans — which have begun a comeback among employers looking to slow rising premiums — are expected to play a prominent role in new online markets, called exchanges, where individuals and small businesses will shop for coverage starting Oct. 1. More

 FDA: New Treatments and Technology

FDA approves novel type of flu vaccine
Thomson Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The U.S. Food and Drug Administration approved the first influenza vaccine made using recombinant DNA technology, rather than live flu virus. Flublok, made by Protein Sciences Corp, was approved for the prevention of seasonal influenza in people 18 through 49 years of age, the regulatory agency said. FDA said that unlike current vaccines Flublok does not use the influenza virus or eggs in its production. More

FDA seeks to tighten regulation of all-metal hip implants
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
After an estimated 500,000 patients in the United States have received a type of artificial hip that is failing early in many cases, the Food and Drug Administration is proposing rules that could stop manufacturers from selling such implants. More

"An estimated 1.15 million people in the United States were living with HIV by the end of 2009, according to the Centers for Disease Control and Prevention."


Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Jan. 17, 2013
Jan. 10, 2013
Jan. 3, 2012
Dec, 27, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063